CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Elegoo, a rapidly developing brand in global smart manufacturing, is proud to debut Jupiter 2, the latest addition to the ...

Two years after Neil Armstrong walked on the Moon, US president Richard Nixon declared a new frontier in American scientific ...

Curve, the digital wallet that saves you money, announced today it has secured a £37M investment led by Hanaco Ventures, with participation of existing shareholders such as Fuel Ventures, IDC, Outward ...

Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk myelodysplastic syndrome.

Experts discuss effective communication strategies for managing patient and caregiver expectations about treatment adverse ...

Experts discuss how to balance treatment intensity with maintaining quality of life, particularly in patients with advanced-stage disease.